Publikation:

Lapachol acetylglycosylation enhances its cytotoxic and pro-apoptotic activities in HL60 cells

Lade...
Vorschaubild

Dateien

Zu diesem Dokument gibt es keine Dateien.

Datum

2020

Autor:innen

Marques, Lucas Bonfim
Ottoni, Flaviano Melo
Xavier Pinto, Mauro Cunha
Ribeiro, Juliana Martins
de Sousa, Fernanda S.
Weinlich, Ricardo
de Souza-Fagundes, Elaine Maria
et al.

Herausgeber:innen

Kontakt

ISSN der Zeitschrift

Electronic ISSN

ISBN

Bibliografische Daten

Verlag

Schriftenreihe

Auflagebezeichnung

URI (zitierfähiger Link)
ArXiv-ID

Internationale Patentnummer

Angaben zur Forschungsförderung

Projekt

Open Access-Veröffentlichung
Core Facility der Universität Konstanz

Gesperrt bis

Titel in einer weiteren Sprache

Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published

Erschienen in

Toxicology in Vitro. Elsevier. 2020, 65, pp. 104772. ISSN 0887-2333. eISSN 1879-3177. Available under: doi: 10.1016/j.tiv.2020.104772

Zusammenfassung

Lapachol is a plant-derived naphthoquinone that kills several types of cancer cells. Derivatives of this molecule may therefore prove to be useful chemotherapeutic agents. In this study, we explored whether glycosylation increases the cytotoxic potency of lapachol towards HL-60 human leukemia cells. Two beta-glycosides were synthesized and characterized: LA4A (lapachol-β-glucoside) and LA4C (lapachol-N-acetylglucosamine-β-glucoside). The sugar moieties of both novel molecules were per-acetylated to facilitate cellular uptake. The IC50 values (in μM) for LA4A (5.7) and LA4C (5.3) were lower than those for lapachol (25). LA4A and LA4C triggered typical signs of apoptosis, such as the exposure of phosphatidylserine on the outside of cells, chromatin condensation, DNA fragmentation and a decrease of the mitochondrial transmembrane potential (ΔΨm) prior to cell lysis. Moreover, DNA fragmentation triggered by the lapachol-glycosides was reduced by pre-treatment with the caspase inhibitor, z-VAD-fmk. While LA4A and LA4C activated caspases-3 and -9, lapachol failed to activate these apoptotic proteases, even when used at high concentrations. Finally, the toxicity of lapachol and its derivatives was also tested on non-tumor cells. We used human peripheral neurons (PeriTox test) to evaluate the side effect potential of these compounds. LA4C was clearly less toxic than LA4A. We conclude that LA4C had the most favorable profile as drug candidate (high tumor cell toxicity, reduced neurotoxicity). In general, this study shows that the cytotoxicity of lapachol towards HL-60 can be enhanced by glycosylation, and that the therapeutic ratio may be modified by the type of sugar added.

Zusammenfassung in einer weiteren Sprache

Fachgebiet (DDC)
570 Biowissenschaften, Biologie

Schlagwörter

Lapachol, Glycosylation, Anticancer drugs, Apoptosis

Konferenz

Rezension
undefined / . - undefined, undefined

Forschungsvorhaben

Organisationseinheiten

Zeitschriftenheft

Zugehörige Datensätze in KOPS

Zitieren

ISO 690MARQUES, Lucas Bonfim, Flaviano Melo OTTONI, Mauro Cunha XAVIER PINTO, Juliana Martins RIBEIRO, Fernanda S. DE SOUSA, Ricardo WEINLICH, Jaffar KISITU, Anna-Katharina HOLZER, Marcel LEIST, Elaine Maria DE SOUZA-FAGUNDES, 2020. Lapachol acetylglycosylation enhances its cytotoxic and pro-apoptotic activities in HL60 cells. In: Toxicology in Vitro. Elsevier. 2020, 65, pp. 104772. ISSN 0887-2333. eISSN 1879-3177. Available under: doi: 10.1016/j.tiv.2020.104772
BibTex
@article{Marques2020-06Lapac-48280,
  year={2020},
  doi={10.1016/j.tiv.2020.104772},
  title={Lapachol acetylglycosylation enhances its cytotoxic and pro-apoptotic activities in HL60 cells},
  volume={65},
  issn={0887-2333},
  journal={Toxicology in Vitro},
  author={Marques, Lucas Bonfim and Ottoni, Flaviano Melo and Xavier Pinto, Mauro Cunha and Ribeiro, Juliana Martins and de Sousa, Fernanda S. and Weinlich, Ricardo and Kisitu, Jaffar and Holzer, Anna-Katharina and Leist, Marcel and de Souza-Fagundes, Elaine Maria}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/48280">
    <dc:contributor>Weinlich, Ricardo</dc:contributor>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:contributor>Marques, Lucas Bonfim</dc:contributor>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-20T12:38:10Z</dcterms:available>
    <dcterms:abstract xml:lang="eng">Lapachol is a plant-derived naphthoquinone that kills several types of cancer cells. Derivatives of this molecule may therefore prove to be useful chemotherapeutic agents. In this study, we explored whether glycosylation increases the cytotoxic potency of lapachol towards HL-60 human leukemia cells. Two beta-glycosides were synthesized and characterized: LA4A (lapachol-β-glucoside) and LA4C (lapachol-N-acetylglucosamine-β-glucoside). The sugar moieties of both novel molecules were per-acetylated to facilitate cellular uptake. The IC50 values (in μM) for LA4A (5.7) and LA4C (5.3) were lower than those for lapachol (25). LA4A and LA4C triggered typical signs of apoptosis, such as the exposure of phosphatidylserine on the outside of cells, chromatin condensation, DNA fragmentation and a decrease of the mitochondrial transmembrane potential (ΔΨm) prior to cell lysis. Moreover, DNA fragmentation triggered by the lapachol-glycosides was reduced by pre-treatment with the caspase inhibitor, z-VAD-fmk. While LA4A and LA4C activated caspases-3 and -9, lapachol failed to activate these apoptotic proteases, even when used at high concentrations. Finally, the toxicity of lapachol and its derivatives was also tested on non-tumor cells. We used human peripheral neurons (PeriTox test) to evaluate the side effect potential of these compounds. LA4C was clearly less toxic than LA4A. We conclude that LA4C had the most favorable profile as drug candidate (high tumor cell toxicity, reduced neurotoxicity). In general, this study shows that the cytotoxicity of lapachol towards HL-60 can be enhanced by glycosylation, and that the therapeutic ratio may be modified by the type of sugar added.</dcterms:abstract>
    <dc:creator>Ribeiro, Juliana Martins</dc:creator>
    <dc:creator>Leist, Marcel</dc:creator>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dcterms:title>Lapachol acetylglycosylation enhances its cytotoxic and pro-apoptotic activities in HL60 cells</dcterms:title>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/48280"/>
    <dc:contributor>Ribeiro, Juliana Martins</dc:contributor>
    <dc:contributor>Kisitu, Jaffar</dc:contributor>
    <dc:contributor>Xavier Pinto, Mauro Cunha</dc:contributor>
    <dc:creator>de Sousa, Fernanda S.</dc:creator>
    <dc:creator>Weinlich, Ricardo</dc:creator>
    <dc:creator>Ottoni, Flaviano Melo</dc:creator>
    <dc:creator>Holzer, Anna-Katharina</dc:creator>
    <dc:creator>Xavier Pinto, Mauro Cunha</dc:creator>
    <dc:contributor>de Sousa, Fernanda S.</dc:contributor>
    <dc:creator>de Souza-Fagundes, Elaine Maria</dc:creator>
    <dc:creator>Marques, Lucas Bonfim</dc:creator>
    <dc:contributor>de Souza-Fagundes, Elaine Maria</dc:contributor>
    <dc:contributor>Holzer, Anna-Katharina</dc:contributor>
    <dc:contributor>Leist, Marcel</dc:contributor>
    <dcterms:issued>2020-06</dcterms:issued>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-20T12:38:10Z</dc:date>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:contributor>Ottoni, Flaviano Melo</dc:contributor>
    <dc:creator>Kisitu, Jaffar</dc:creator>
    <dc:language>eng</dc:language>
  </rdf:Description>
</rdf:RDF>

Interner Vermerk

xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter

Kontakt
URL der Originalveröffentl.

Prüfdatum der URL

Prüfungsdatum der Dissertation

Finanzierungsart

Kommentar zur Publikation

Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Ja
Diese Publikation teilen